52
Views
8
CrossRef citations to date
0
Altmetric
Article

DGCR14 Induces Il17a Gene Expression through the RORγ/BAZ1B/RSKS2 Complex

Pages 344-355 | Received 10 Jul 2014, Accepted 27 Oct 2014, Published online: 20 Mar 2023

REFERENCES

  • Medvedev A, Yan ZH, Hirose T, Giguere V, Jetten AM. 1996. Cloning of a cDNA encoding the murine orphan receptor RZR/ROR gamma and characterization of its response element. Gene 181:199–206. http://dx.doi.org/10.1016/S0378-1119(96)00504-5.
  • Jetten AM. 2009. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7:e003. http://dx.doi.org/10.1621/nrs.07003.
  • Takeda Y, Kang HS, Freudenberg J, DeGraff LM, Jothi R, Jetten AM. 2014. Retinoic acid-related orphan receptor gamma (RORgamma): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. PLoS Genet 10:e1004331. http://dx.doi.org/10.1371/journal.pgen.1004331.
  • Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F, Jetten AM. 2000. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci U S A 97:10132–10137. http://dx.doi.org/10.1073/pnas.97.18.10132.
  • Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133. http://dx.doi.org/10.1016/j.cell.2006.07.035.
  • Kumar N, Lyda B, Chang MR, Lauer JL, Solt LA, Burris TP, Kamenecka TM, Griffin PR. 2012. Identification of SR2211: a potent synthetic RORgamma-selective modulator. ACS Chem Biol 7:672–677. http://dx.doi.org/10.1021/cb200496y.
  • Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovic D, Schurer SC, Xu J, Wagoner G, Drew PD, Griffin PR, Burris TP. 2011. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472:491–494. http://dx.doi.org/10.1038/nature10075.
  • Wang Y, Kumar N, Nuhant P, Cameron MD, Istrate MA, Roush WR, Griffin PR, Burris TP. 2010. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma. ACS Chem Biol 5:1029–1034. http://dx.doi.org/10.1021/cb100223d.
  • Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, Busby SA, Garcia-Ordonez RD, Burris TP, Griffin PR. 2010. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 77:228–236. http://dx.doi.org/10.1124/mol.109.060905.
  • Stavreva DA, Varticovski L, Hager GL. 2012. Complex dynamics of transcription regulation. Biochim Biophys Acta 1819:657–666. http://dx.doi.org/10.1016/j.bbagrm.2012.03.004.
  • Bannister AJ, Kouzarides T. 2011. Regulation of chromatin by histone modifications. Cell Res 21:381–395. http://dx.doi.org/10.1038/cr.2011.22.
  • Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511–526. http://dx.doi.org/10.1016/S0092-8674(04)00133-3.
  • Métivier R, Reid G, Gannon F. 2006. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep 7:161–167. http://dx.doi.org/10.1038/sj.embor.7400626.
  • Ichiyama K, Yoshida H, Wakabayashi Y, Chinen T, Saeki K, Nakaya M, Takaesu G, Hori S, Yoshimura A, Kobayashi T. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J Biol Chem 283:17003–17008. http://dx.doi.org/10.1074/jbc.M801286200.
  • Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489. http://dx.doi.org/10.1093/nar/11.5.1475.
  • Takada I, Tsuji N, Youn MY, Fujiyama S, Okada M, Imai Y, Kondo S, Kitakawa H, Yasuda H, Kato S. 2010. Purification and identification of estrogen receptor alpha co-regulators in osteoclasts. Ann N Y Acad Sci 1192:201–207. http://dx.doi.org/10.1111/j.1749-6632.2009.05215.x.
  • Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, Muto G, Shichita T, Takahashi R, Yoshimura A. 2011. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin. Immunity 34:741–754. http://dx.doi.org/10.1016/j.immuni.2011.02.021.
  • Wakabayashi Y, Tamiya T, Takada I, Fukaya T, Sugiyama Y, Inoue N, Kimura A, Morita R, Kashiwagi I, Takimoto T, Nomura M, Yoshimura A. 2011. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-beta-Smad pathway. J Biol Chem 286:35456–35465. http://dx.doi.org/10.1074/jbc.M111.236794.
  • Kubo M, Kincaid RL, Webb DR, Ransom JT. 1994. The Ca2+/calmodulin-activated, phosphoprotein phosphatase calcineurin is sufficient for positive transcriptional regulation of the mouse IL-4 gene. Int Immunol 6:179–188. http://dx.doi.org/10.1093/intimm/6.2.179.
  • Gong W, Emanuel BS, Galili N, Kim DH, Roe B, Driscoll DA, Budarf ML. 1997. Structural and mutational analysis of a conserved gene (DGSI) from the minimal DiGeorge syndrome critical region. Hum Mol Genet 6:267–276. http://dx.doi.org/10.1093/hmg/6.2.267.
  • Lindsay EA, Rizzu P, Antonacci R, Jurecic V, Delmas-Mata J, Lee CC, Kim UJ, Scambler PJ, Baldini A. 1996. A transcription map in the CATCH22 critical region: identification, mapping, and ordering of four novel transcripts expressed in heart. Genomics 32:104–112. http://dx.doi.org/10.1006/geno.1996.0082.
  • Gennery AR. 2012. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 69:17–27. http://dx.doi.org/10.1007/s00018-011-0842-z.
  • Lindsay EA, Harvey EL, Scambler PJ, Baldini A. 1998. ES2, a gene deleted in DiGeorge syndrome, encodes a nuclear protein and is expressed during early mouse development, where it shares an expression domain with a Goosecoid-like gene. Hum Mol Genet 7:629–635. http://dx.doi.org/10.1093/hmg/7.4.629.
  • Rizzu P, Lindsay EA, Taylor C, O'Donnell H, Levy A, Scambler P, Baldini A. 1996. Cloning and comparative mapping of a gene from the commonly deleted region of DiGeorge and Velocardiofacial syndromes conserved in C. elegans. Mamm Genome 7:639–643. http://dx.doi.org/10.1007/s003359900197.
  • Taricani L, Tejada ML, Young PG. 2002. The fission yeast ES2 homologue, Bis1, interacts with the Ish1 stress-responsive nuclear envelope protein. J Biol Chem 277:10562–10572. http://dx.doi.org/10.1074/jbc.M110686200.
  • Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E, Vijayadamodar G, Pochart P, Machineni H, Welsh M, Kong Y, Zerhusen B, Malcolm R, Varrone Z, Collis A, Minto M, Burgess S, McDaniel L, Stimpson E, Spriggs F, Williams J, Neurath K, Ioime N, Agee M, Voss E, Furtak K, Renzulli R, Aanensen N, Carrolla S, Bickelhaupt E, Lazovatsky Y, DaSilva A, Zhong J, Stanyon CA, Finley RL, Jr, White KP, Braverman M, Jarvie T, Gold S, Leach M, Knight J, Shimkets RA, McKenna MP, Chant J, Rothberg JM. 2003. A protein interaction map of Drosophila melanogaster. Science 302:1727–1736. http://dx.doi.org/10.1126/science.1090289.
  • Hegele A, Kamburov A, Grossmann A, Sourlis C, Wowro S, Weimann M, Will CL, Pena V, Luhrmann R, Stelzl U. 2012. Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell 45:567–580. http://dx.doi.org/10.1016/j.molcel.2011.12.034.
  • Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405–1428. http://dx.doi.org/10.1101/gad.1424806.
  • Cavellán E, Asp P, Percipalle P, Farrants AK. 2006. The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription. J Biol Chem 281:16264–16271. http://dx.doi.org/10.1074/jbc.M600233200.
  • Barnett C, Krebs JE. 2011. WSTF does it all: a multifunctional protein in transcription, repair, and replication. Biochem Cell Biol 89:12–23. http://dx.doi.org/10.1139/O10-114.
  • Unk I, Hajdu I, Fatyol K, Szakal B, Blastyak A, Bermudez V, Hurwitz J, Prakash L, Prakash S, Haracska L. 2006. Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen. Proc Natl Acad Sci U S A 103:18107–18112. http://dx.doi.org/10.1073/pnas.0608595103.
  • Romeo Y, Zhang X, Roux PP. 2012. Regulation and function of the RSK family of protein kinases. Biochem J 441:553–569. http://dx.doi.org/10.1042/BJ20110289.
  • Clark DE, Poteet-Smith CE, Smith JA, Lannigan DA. 2001. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain. EMBO J 20:3484–3494. http://dx.doi.org/10.1093/emboj/20.13.3484.
  • Huang ZM, Wu J, Jia ZC, Tian Y, Tang J, Tang Y, Wang Y, Wu YZ, Ni B. 2012. Identification of interacting proteins of retinoid-related orphan nuclear receptor gamma in HepG2 cells. BMB Rep 45:331–336. http://dx.doi.org/10.5483/BMBRep.2012.45.6.249.
  • Mudter J, Yu J, Zufferey C, Brustle A, Wirtz S, Weigmann B, Hoffman A, Schenk M, Galle PR, Lehr HA, Mueller C, Lohoff M, Neurath MF. 2011. IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent TH17 colitis in vivo. Inflamm Bowel Dis 17:1343–1358. http://dx.doi.org/10.1002/ibd.21476.
  • Zhang F, Meng G, Strober W. 2008. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 9:1297–1306. http://dx.doi.org/10.1038/ni.1663.
  • Gomez-Rodriguez J, Sahu N, Handon R, Davidson TS, Anderson SM, Kirby MR, August A, Schwartzberg PL. 2009. Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 31:587–597. http://dx.doi.org/10.1016/j.immuni.2009.07.009.
  • Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O'Shea JJ. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A 103:8137–8142. http://dx.doi.org/10.1073/pnas.0600666103.
  • Lin JX, Spolski R, Leonard WJ. 2008. Critical role for Rsk2 in T-lymphocyte activation. Blood 111:525–533. http://dx.doi.org/10.1182/blood-2007-02-072207.
  • Ashe A, Morgan DK, Whitelaw NC, Bruxner TJ, Vickaryous NK, Cox LL, Butterfield NC, Wicking C, Blewitt ME, Wilkins SJ, Anderson GJ, Cox TC, Whitelaw E. 2008. A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development. Genome Biol 9:R182. http://dx.doi.org/10.1186/gb-2008-9-12-r182.
  • Sapkota GP, Cummings L, Newell FS, Armstrong C, Bain J, Frodin M, Grauert M, Hoffmann M, Schnapp G, Steegmaier M, Cohen P, Alessi DR. 2007. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401:29–38. http://dx.doi.org/10.1042/BJ20061088.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.